A strong coordinated drug discovery activity at National level can contribute to a robust social and economic development engine, based on a long-term sustainable technological competitive differentiation.

The AccelBio Open Call was a unique opportunity to develop a project that opens new avenues for advancing research in Absence epilepsy.

I want our work to go beyond publications and actually reach patients. Running an academic lab on a potentially breakthrough fundamental science project, we started collaborating with AccelBio. This gave us the chance to translate our science into real clinical progress.

Beyond valuable advice, connections, and access to additional scientific platforms, they bring the rigour, models, and regulatory insight most academic labs simply lack. Together, we now have a real shot at making a clinical difference.